Life Sciences & Biopharma

Life Science and Biopharma vertical focusses on disruptive innovations in the field such as precision medicine, genomics, next-generation sequencing, molecular biology, and in-vitro diagnostics among other new-age treatment therapies. This vertical keeps track of rapid growth of gene therapy, cell therapy, biologics, and next-generation vaccines that are driving the market, as well as on improves visibility on emerging trends, regulations, and competitor landscape that promises to address key challenges in the healthcare industry.

To Know more about Life Sciences & Biopharma Practice Contact Us Or email us [email protected]

Top Market Research Reports:

Published
Upcoming

Global Carrier Screening Market: Focus on Product Type, Technology Type,18 Countries Data, Autosomal Recessive Disorders, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2029

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.

SINGLE USER ( 5000 ) SITE LICENSE ( 6500 ) GLOBAL (ENTERPRISE) ( 8000 )

Life Sciences & Biopharma

Top Market Research Reports:

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.

The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.

The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.

The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.

The global anti-aging devices market was estimated at $6.37 billion in 2017 and is anticipated to reach $15.77 billion by 2028.

The global industrial microbiological QC market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.

The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.

The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.

The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.

The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.

The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.

The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025. The growing demand for enzymes in various industries is the major reason for the growth of this market.

The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.

The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.

The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.

The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.

The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.

NEWSLETTER SIGNUP

Upcoming Events

Robotics Simulators: An Emerging Frontier in the Era of Healthcare Robotics

Big Data: The Goldmine of Precision Agriculture

Commercial UAV Expo Americas

Categories

Twitter Feeds

Get yourself updated on key emerging technology markets